These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19021293)

  • 61. Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice.
    Nilsson P; Loganathan K; Sekiguchi M; Winblad B; Iwata N; Saido TC; Tjernberg LO
    Proteomics; 2015 Oct; 15(19):3349-55. PubMed ID: 26194619
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes.
    Hu M; Zhang J; Yang J; Cao Y; Qi J
    J Mol Neurosci; 2018 Sep; 66(1):1-9. PubMed ID: 30062438
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
    Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
    Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
    Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain.
    Rofo F; Ugur Yilmaz C; Metzendorf N; Gustavsson T; Beretta C; Erlandsson A; Sehlin D; Syvänen S; Nilsson P; Hultqvist G
    Theranostics; 2021; 11(2):789-804. PubMed ID: 33391505
    [No Abstract]   [Full Text] [Related]  

  • 66. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice.
    Kawahara K; Suenobu M; Yoshida A; Koga K; Hyodo A; Ohtsuka H; Kuniyasu A; Tamamaki N; Sugimoto Y; Nakayama H
    Neuroscience; 2012 Apr; 207():243-60. PubMed ID: 22342341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease.
    Kalinin S; Richardson JC; Feinstein DL
    Curr Alzheimer Res; 2009 Oct; 6(5):431-7. PubMed ID: 19874267
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Peripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's disease.
    Spencer B; Marr RA; Gindi R; Potkar R; Michael S; Adame A; Rockenstein E; Verma IM; Masliah E
    PLoS One; 2011 Jan; 6(1):e16575. PubMed ID: 21304989
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in mice.
    Walker JR; Pacoma R; Watson J; Ou W; Alves J; Mason DE; Peters EC; Urbina HD; Welzel G; Althage A; Liu B; Tuntland T; Jacobson LH; Harris JL; Schumacher AM
    J Neurosci; 2013 Feb; 33(6):2457-64. PubMed ID: 23392674
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
    Becker M; Moore A; Naughton M; Boland B; Siems WE; Walther T
    Neurosci Lett; 2018 Nov; 686():74-79. PubMed ID: 30144539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neprilysin and amyloid beta peptide degradation.
    Hersh LB; Rodgers DW
    Curr Alzheimer Res; 2008 Apr; 5(2):225-31. PubMed ID: 18393807
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Galectin-3 promotes Aβ oligomerization and Aβ toxicity in a mouse model of Alzheimer's disease.
    Tao CC; Cheng KM; Ma YL; Hsu WL; Chen YC; Fuh JL; Lee WJ; Chao CC; Lee EHY
    Cell Death Differ; 2020 Jan; 27(1):192-209. PubMed ID: 31127200
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models.
    Zhao L; Gottesdiener AJ; Parmar M; Li M; Kaminsky SM; Chiuchiolo MJ; Sondhi D; Sullivan PM; Holtzman DM; Crystal RG; Paul SM
    Neurobiol Aging; 2016 Aug; 44():159-172. PubMed ID: 27318144
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease.
    Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM
    FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of Alzheimer's disease.
    Chen PT; Chen ZT; Hou WC; Yu LC; Chen RP
    Sci Rep; 2016 Jul; 6():29760. PubMed ID: 27407064
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo.
    Mohajeri MH; Wollmer MA; Nitsch RM
    J Biol Chem; 2002 Sep; 277(38):35460-5. PubMed ID: 12105192
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nobiletin Reduces Intracellular and Extracellular β-Amyloid in iPS Cell-Derived Alzheimer's Disease Model Neurons.
    Kimura J; Shimizu K; Kajima K; Yokosuka A; Mimaki Y; Oku N; Ohizumi Y
    Biol Pharm Bull; 2018; 41(4):451-457. PubMed ID: 29607920
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.